Skip to main content
Erschienen in: Current Pain and Headache Reports 6/2014

01.06.2014 | Cancer Pain (D Marcus, Section Editor)

Understanding Placebo and Nocebo Responses for Pain Management

verfasst von: Luana Colloca, Christian Grillon

Erschienen in: Current Pain and Headache Reports | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Placebo analgesia makes individuals experience relief of their pain simply by virtue of the anticipation of a benefit. A reduction of pain can occur also when placebos follow the administration of active and effective painkillers. In fact, studies indicate that placebos mimic the action of active treatments and promote the endogenous release of opioids in both humans and animals. Finally, social support and observational learning also lead to analgesic effects. Thus, different psychological factors and situations induce expectations of analgesia facilitating the activation of the top-down systems for pain control along with the release of endogenous mediators crucially involved in placebo-induced benefits. Recent scientific investigation in the field of brain imaging is opening new avenues to understanding the cognitive mechanisms and neurobiological substrates of expectation-induced pain modulation. Gaining deeper knowledge of top-down mechanisms of pain modulation has enormous implications for personalizing and optimizing pain management.
Literatur
1.••
Zurück zum Zitat Colloca L, Flaten MA, Meissner K. Placebo and Pain: From bench to bedside. Oxford, UK: Elsevier; 2013. This book is the first comprehensive presentation of the placebo and nocebo phenomena in the area of pain and integrates a broad range of contributions discussing: (a) historical and methodological aspects of the placebo/nocebo effects; (b) biological and psychological mechanisms of placebo analgesia and nocebo hyperlagesia; and (c), implications of the placebo and nocebo effects for clinical research and pain management. Colloca L, Flaten MA, Meissner K. Placebo and Pain: From bench to bedside. Oxford, UK: Elsevier; 2013. This book is the first comprehensive presentation of the placebo and nocebo phenomena in the area of pain and integrates a broad range of contributions discussing: (a) historical and methodological aspects of the placebo/nocebo effects; (b) biological and psychological mechanisms of placebo analgesia and nocebo hyperlagesia; and (c), implications of the placebo and nocebo effects for clinical research and pain management.
2.•
Zurück zum Zitat Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and neurobiological mechanisms. Pain. 2013;154:511–4. This review article provides an accurate and succinct up-to-date report on current knowledge regarding the neurobiological aspects of placebo-induced modulation of pain.PubMedCentralPubMedCrossRef Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and neurobiological mechanisms. Pain. 2013;154:511–4. This review article provides an accurate and succinct up-to-date report on current knowledge regarding the neurobiological aspects of placebo-induced modulation of pain.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatr. 2011;24:149–55.CrossRef Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatr. 2011;24:149–55.CrossRef
4.
Zurück zum Zitat Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain. 2006;124:126–33.PubMedCrossRef Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain. 2006;124:126–33.PubMedCrossRef
6.
Zurück zum Zitat Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136:211–8.PubMedCrossRef Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136:211–8.PubMedCrossRef
7.
Zurück zum Zitat Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F, et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain. 2008;139:306–14. Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F, et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain. 2008;139:306–14.
8.
Zurück zum Zitat Klinger R, Soost S, Flor H, Worm M. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain. 2007;128:31–9.PubMedCrossRef Klinger R, Soost S, Flor H, Worm M. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain. 2007;128:31–9.PubMedCrossRef
9.
Zurück zum Zitat Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 1990;43:121–8.PubMedCrossRef Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 1990;43:121–8.PubMedCrossRef
10.
Zurück zum Zitat Fiorio M et al. Enhancing non-noxious perception: behavioural and neurophysiological correlates of a placebo-like manipulation. Neuroscience. 2012;217:96–104.PubMedCrossRef Fiorio M et al. Enhancing non-noxious perception: behavioural and neurophysiological correlates of a placebo-like manipulation. Neuroscience. 2012;217:96–104.PubMedCrossRef
11.
Zurück zum Zitat Fiorio M, Recchia S, Corra F, Tinazzi M. Behavioral and neurophysiological investigation of the influence of verbal suggestion on tactile perception. Neuroscience. 2014;258:332–9.PubMedCrossRef Fiorio M, Recchia S, Corra F, Tinazzi M. Behavioral and neurophysiological investigation of the influence of verbal suggestion on tactile perception. Neuroscience. 2014;258:332–9.PubMedCrossRef
12.
Zurück zum Zitat Jensen KB, Kaptchuk TJ, Kirsch I, Raicek J, Lindstrom KM, Berna C, et al. Nonconscious activation of placebo and nocebo pain responses. Proc Natl Acad Sci U S A. 2012;109:15959–64. Jensen KB, Kaptchuk TJ, Kirsch I, Raicek J, Lindstrom KM, Berna C, et al. Nonconscious activation of placebo and nocebo pain responses. Proc Natl Acad Sci U S A. 2012;109:15959–64.
13.
Zurück zum Zitat Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci. 2011;366:1922–30.PubMedCentralPubMedCrossRef Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci. 2011;366:1922–30.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Amanzio M, Benedetti F. Neuropharmacologic dissection of placebo analgesia: expectation-activated opioid systems vs conditioning-activated specific subsystems. J Neurosci. 1999;19:484–94.PubMed Amanzio M, Benedetti F. Neuropharmacologic dissection of placebo analgesia: expectation-activated opioid systems vs conditioning-activated specific subsystems. J Neurosci. 1999;19:484–94.PubMed
15.••
Zurück zum Zitat Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17:1228–30. This article is the first indirect pharmacologic evidence that the cannabinoid system accounts for placebo analgesic responses together with the opioid system.PubMedCrossRef Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17:1228–30. This article is the first indirect pharmacologic evidence that the cannabinoid system accounts for placebo analgesic responses together with the opioid system.PubMedCrossRef
16.
Zurück zum Zitat Benedetti F, Pollo A, Colloca L. Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? J Neurosci. 2007;27:11934–9.PubMedCrossRef Benedetti F, Pollo A, Colloca L. Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? J Neurosci. 2007;27:11934–9.PubMedCrossRef
17.
Zurück zum Zitat Guo JY, Wang JY, Luo F. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems. J Psychopharmacol. 2010;24:1561–7.PubMedCrossRef Guo JY, Wang JY, Luo F. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems. J Psychopharmacol. 2010;24:1561–7.PubMedCrossRef
18.
Zurück zum Zitat Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain. 2009;144:28–34.PubMedCrossRef Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain. 2009;144:28–34.PubMedCrossRef
19.
Zurück zum Zitat Swider K, Babel P. The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. Pain. 2013;154:1312–7.PubMedCrossRef Swider K, Babel P. The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. Pain. 2013;154:1312–7.PubMedCrossRef
21.
Zurück zum Zitat Vogtle E, Barke A, Kroner-Herwig B. Nocebo hyperalgesia induced by social observational learning. Pain. 2013;154:1427–33.PubMedCrossRef Vogtle E, Barke A, Kroner-Herwig B. Nocebo hyperalgesia induced by social observational learning. Pain. 2013;154:1427–33.PubMedCrossRef
23.
Zurück zum Zitat Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt vs covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3:679–84.PubMedCrossRef Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt vs covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3:679–84.PubMedCrossRef
26.
Zurück zum Zitat Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147:260–71.PubMedCrossRef Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147:260–71.PubMedCrossRef
27.
Zurück zum Zitat Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 2006;120:8–15.PubMedCrossRef Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 2006;120:8–15.PubMedCrossRef
28.
Zurück zum Zitat Craggs JG, Price DD, Perlstein WM, Verne GN, Robinson ME. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain. 2008;139:660–9.PubMedCentralPubMedCrossRef Craggs JG, Price DD, Perlstein WM, Verne GN, Robinson ME. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain. 2008;139:660–9.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63:533–43. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63:533–43.
30.
Zurück zum Zitat Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7.
31.
Zurück zum Zitat Krummenacher P, Candia V, Folkers G, Schedlowski M, Schonbachler G. Prefrontal cortex modulates placebo analgesia. Pain. 2010;148:368–74.PubMedCrossRef Krummenacher P, Candia V, Folkers G, Schedlowski M, Schonbachler G. Prefrontal cortex modulates placebo analgesia. Pain. 2010;148:368–74.PubMedCrossRef
32.
Zurück zum Zitat Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. Pain. 2010;151:816–24. Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. Pain. 2010;151:816–24.
33.
Zurück zum Zitat Eippert F, Finsterbusch J, Bingel U, Buchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science. 2009;326:404.PubMedCrossRef Eippert F, Finsterbusch J, Bingel U, Buchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science. 2009;326:404.PubMedCrossRef
34.••
Zurück zum Zitat Geuter S, Buchel C. Facilitation of pain in the human spinal cord by nocebo treatment. J Neurosci. 2013;33:13784–90. his article provides evidence that nocebo manipulations leads to increased pain perception, lowered pain thresholds, and increased BOLD activity in the spinal corn. The peak activation in the ipsilateral spinal cord was at the same rostro-caudal level as shown in a twin previous study by Eippert et al (2009), in which placebo manipulations were used. Together these studies corroborate the notion that placebo and nocebo modulate pain bidirectionally at the level of the spinal cord.PubMedCrossRef Geuter S, Buchel C. Facilitation of pain in the human spinal cord by nocebo treatment. J Neurosci. 2013;33:13784–90. his article provides evidence that nocebo manipulations leads to increased pain perception, lowered pain thresholds, and increased BOLD activity in the spinal corn. The peak activation in the ipsilateral spinal cord was at the same rostro-caudal level as shown in a twin previous study by Eippert et al (2009), in which placebo manipulations were used. Together these studies corroborate the notion that placebo and nocebo modulate pain bidirectionally at the level of the spinal cord.PubMedCrossRef
35.
Zurück zum Zitat Fields HL. Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res. 2000;122:245–53.PubMedCrossRef Fields HL. Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res. 2000;122:245–53.PubMedCrossRef
38.
39.
Zurück zum Zitat Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci. 2009;29:4882–7.PubMedCrossRef Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci. 2009;29:4882–7.PubMedCrossRef
40.
Zurück zum Zitat Kong J, Jensen K, Loiotile R, Cheetham A, Wey H-Y, Tan Y, et al. Functional connectivity of the fronto-parietal network predicts cognitive modulation of pain. Pain. 2013;154:459–67. Kong J, Jensen K, Loiotile R, Cheetham A, Wey H-Y, Tan Y, et al. Functional connectivity of the fronto-parietal network predicts cognitive modulation of pain. Pain. 2013;154:459–67.
42.•
Zurück zum Zitat Stein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain. 2012;153:2210–7. The authors demonstrate that structural connectivity indexed by fractional anisotropy correlates with placebo analgesic responses. Positive correlations between the fractional anisotropy and individual placebo analgesic responses were found in the dorsalateral prefrontal cortex, left rostral anterior cingulate cortex, and the periacqueductal gray. The white matter integrity within and between regions of the descending pain modulatory network is crucially linked to the placebo-induced control of pain.PubMedCrossRef Stein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain. 2012;153:2210–7. The authors demonstrate that structural connectivity indexed by fractional anisotropy correlates with placebo analgesic responses. Positive correlations between the fractional anisotropy and individual placebo analgesic responses were found in the dorsalateral prefrontal cortex, left rostral anterior cingulate cortex, and the periacqueductal gray. The white matter integrity within and between regions of the descending pain modulatory network is crucially linked to the placebo-induced control of pain.PubMedCrossRef
43.
Zurück zum Zitat Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26:12014–22.PubMedCrossRef Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26:12014–22.PubMedCrossRef
44.
Zurück zum Zitat Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U. Effect of oxytocin on placebo analgesia: a randomized study. JAMA. 2013;310:1733–5.PubMedCrossRef Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U. Effect of oxytocin on placebo analgesia: a randomized study. JAMA. 2013;310:1733–5.PubMedCrossRef
45.
46.
Zurück zum Zitat Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25:7754–62. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25:7754–62.
47.
Zurück zum Zitat Campbell A. Oxytocin and human social behavior. Pers Soc Psychol Rev. 2010;14:281–295. Campbell A. Oxytocin and human social behavior. Pers Soc Psychol Rev. 2010;14:281–295.
48.
Zurück zum Zitat Heinrichs M, Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res. 2008;170:337–50.PubMedCrossRef Heinrichs M, Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res. 2008;170:337–50.PubMedCrossRef
49.
Zurück zum Zitat Hall KT, Kaptchuk TJ. Genetic biomarkers of placebo response: what could it mean for future trial design? Clin Investig. 2013;3:11–314. Hall KT, Kaptchuk TJ. Genetic biomarkers of placebo response: what could it mean for future trial design? Clin Investig. 2013;3:11–314.
50.
Zurück zum Zitat Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, et al. Catechol-O-Methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012;7:e48135. Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, et al. Catechol-O-Methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012;7:e48135.
51.
Zurück zum Zitat Pecina M, et al. FAAH selectively influences placebo effects. Mol Psychiatr. 2013;19:385–91. Pecina M, et al. FAAH selectively influences placebo effects. Mol Psychiatr. 2013;19:385–91.
52.
Zurück zum Zitat Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet. 2004;13:2113–9.PubMedCrossRef Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet. 2004;13:2113–9.PubMedCrossRef
53.
Zurück zum Zitat Faria V, Appel L, Ahs F, Linnman C, Pissiota A, Frans O, et al. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder. Neuropsychopharmacology. 2012;37:2222–32. Faria V, Appel L, Ahs F, Linnman C, Pissiota A, Frans O, et al. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder. Neuropsychopharmacology. 2012;37:2222–32.
54.
Zurück zum Zitat Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci. 2008;28:13066–74. Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci. 2008;28:13066–74.
55.
Zurück zum Zitat Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009;29:372–7.PubMedCrossRef Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009;29:372–7.PubMedCrossRef
56.
Zurück zum Zitat Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res. 2005;58:121–7.PubMedCrossRef Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res. 2005;58:121–7.PubMedCrossRef
58.
Zurück zum Zitat Morton DL, Watson A, El-Deredy W, Jones AK. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain. 2009;146:194–8.PubMedCrossRef Morton DL, Watson A, El-Deredy W, Jones AK. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain. 2009;146:194–8.PubMedCrossRef
59.
Zurück zum Zitat De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain. 2002;96:393–402.PubMedCrossRef De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain. 2002;96:393–402.PubMedCrossRef
60.•
Zurück zum Zitat Huber A, Lui F, Porro CA. Hypnotic susceptibility modulates brain activity related to experimental placebo analgesia. Pain. 2013;154:1509–18. The authors report that hypnotic susceptibility is linked to placebo analgesia from a brain imaging perspective. During the anticipatory phase, patients with higher hypnotic susceptibility showed increased anticipatory activity in a right dorsolateral prefrontal cortex and a reduction in functional connectivity within brain regions related to emotional and evaluative pain processing (anterior mid-cingulate cortex/medial prefrontal cortex). Subjects with lower hypnotic susceptibility showed an opposite pattern of fMRI activity and functional connectivity. During placebo-induced analgesia, activity in the regions reflecting attention/arousal (bilateral anterior thalamus/left caudate) and self-related processing (left precuneus and bilateral posterior temporal foci) was negatively related to analgesic placebo responses in patients with higher hypnotic susceptibility.PubMedCrossRef Huber A, Lui F, Porro CA. Hypnotic susceptibility modulates brain activity related to experimental placebo analgesia. Pain. 2013;154:1509–18. The authors report that hypnotic susceptibility is linked to placebo analgesia from a brain imaging perspective. During the anticipatory phase, patients with higher hypnotic susceptibility showed increased anticipatory activity in a right dorsolateral prefrontal cortex and a reduction in functional connectivity within brain regions related to emotional and evaluative pain processing (anterior mid-cingulate cortex/medial prefrontal cortex). Subjects with lower hypnotic susceptibility showed an opposite pattern of fMRI activity and functional connectivity. During placebo-induced analgesia, activity in the regions reflecting attention/arousal (bilateral anterior thalamus/left caudate) and self-related processing (left precuneus and bilateral posterior temporal foci) was negatively related to analgesic placebo responses in patients with higher hypnotic susceptibility.PubMedCrossRef
62.•
Zurück zum Zitat Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS, et al. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology. 2013;38:639–46. This article outlines that some psychological traits trigger the μ-opioid-mediated placebo analgesia. Specifically, ego-resiliency, NEO Altruism, NEO Straightforwardness (positive predictors), and NEO Angry Hostility (negative predictor) traits account for 25% of the variance in the release of endogenous μ-opioids during placebo analgesia. Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS, et al. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology. 2013;38:639–46. This article outlines that some psychological traits trigger the μ-opioid-mediated placebo analgesia. Specifically, ego-resiliency, NEO Altruism, NEO Straightforwardness (positive predictors), and NEO Angry Hostility (negative predictor) traits account for 25% of the variance in the release of endogenous μ-opioids during placebo analgesia.
63.
Zurück zum Zitat Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol. 2007;20:435–9.PubMedCrossRef Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol. 2007;20:435–9.PubMedCrossRef
64.
Zurück zum Zitat Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307:567–8.PubMedCrossRef Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307:567–8.PubMedCrossRef
65.
Zurück zum Zitat Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3:70ra14. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3:70ra14.
66.
Zurück zum Zitat Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205–15.PubMedCrossRef Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205–15.PubMedCrossRef
67.••
Zurück zum Zitat Kessner S, Wiech K, Forkmann K, Ploner M, Bingel U. The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med. 2013;1–2. On days 1 and 2, either a positive or negative treatment experience was induced by combining an inert patch treatment with a conditioning manipulation. Functional magnetic resonance imaging responses were used as a physiological marker of placebo-induced analgesia. The authors found a weaker reduction of pain-related activity in the posterior insula in the negative compared with the positive treatment history group, thus, indicating the treatment history shapes behavioral and brain responses to pain experience. Kessner S, Wiech K, Forkmann K, Ploner M, Bingel U. The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med. 2013;1–2. On days 1 and 2, either a positive or negative treatment experience was induced by combining an inert patch treatment with a conditioning manipulation. Functional magnetic resonance imaging responses were used as a physiological marker of placebo-induced analgesia. The authors found a weaker reduction of pain-related activity in the posterior insula in the negative compared with the positive treatment history group, thus, indicating the treatment history shapes behavioral and brain responses to pain experience.
68.
Zurück zum Zitat Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain. 2010;151:430–9.PubMedCentralPubMedCrossRef Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain. 2010;151:430–9.PubMedCentralPubMedCrossRef
69.
Zurück zum Zitat Andre-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain. 2011;152:1233–7.PubMedCrossRef Andre-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain. 2011;152:1233–7.PubMedCrossRef
Metadaten
Titel
Understanding Placebo and Nocebo Responses for Pain Management
verfasst von
Luana Colloca
Christian Grillon
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 6/2014
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0419-2

Weitere Artikel der Ausgabe 6/2014

Current Pain and Headache Reports 6/2014 Zur Ausgabe

Cancer Pain (D Marcus, Section Editor)

Breakthrough Cancer Pain

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Ultrasound-Guided Stellate Ganglion Block: Safety and Efficacy

Uncommon Headache Syndromes (J Ailani, Section Editor)

Low-Pressure/Spinal Fluid Leak Headache

Cancer Pain (D Marcus, Section Editor)

Using Animal Models to Understand Cancer Pain in Humans

Uncommon Headache Syndromes (J Ailani, Section Editor)

It IS a Tumor- Current Review of Headache and Brain Tumor

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.